# Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

> **NCT00293059** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 190 (actual)

## Conditions studied

- Metrorrhagia

## Interventions

- **DRUG:** Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00293059
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293059, "Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00293059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*